China’s Zhejiang Silk Road Fund has participated in a US$100 million series B round in CMR Surgical Ltd, a British company developing surgical robots. Existing investors including Escala Capital Investments, LGT, Cambridge Innovation Capital and Watrium, also participated in the round, according to CMR Surgical’s announcement. Founded in 2014, the Cambridge-headquartered firm has developed the universal robotic system Versius for minimal access surgery. The company is conducting pre-clinical trials, demonstrating the ability of its Versius system to perform upper gastrointestinal, …

Zhejiang Silk Road Joins In $100M Series B Round In British Surgical Robot Developer CMR Surgical appeared first on China Money Network.